Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.08B |
| 2 |
Microsoft
MSFT
|
+$699M |
| 3 |
Exxon Mobil
XOM
|
+$614M |
| 4 |
Apple
AAPL
|
+$587M |
| 5 |
UnitedHealth
UNH
|
+$448M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$1.1B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$477M |
| 3 |
GE Aerospace
GE
|
+$375M |
| 4 |
AEL
American Equity Investment Life Holding Company
AEL
|
+$271M |
| 5 |
Applied Materials
AMAT
|
+$209M |
Sector Composition
| 1 | Technology | 20.72% |
| 2 | Financials | 16.94% |
| 3 | Industrials | 12.24% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Healthcare | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Arrow Financial
AROW
$479M
| $18.2M | ﹤0.01% |
700,253
+31,268
| +5% | +$815K |
|
2002
Olema Pharmaceuticals
OLMA
$545M
| $18.2M | ﹤0.01% |
1,684,924
-251,233
| -13% | -$2.72M |
|
2003
Prudential
PUK
$35.5B
| $18.2M | ﹤0.01% |
993,525
-11,425
| -1% | -$209K |
|
2004
Schrodinger
SDGR
$1.43B
| $18.2M | ﹤0.01% |
941,019
-107,872
| -10% | -$2.09M |
|
2005
Iovance Biotherapeutics
IOVA
$836M
| $18.2M | ﹤0.01% |
2,265,555
-605,943
| -21% | -$4.86M |
|
2006
Burke & Herbert Financial Services Corp
BHRB
$942M
| $18.1M | ﹤0.01% |
+355,782
| New | +$18.1M |
|
2007
Vicor
VICR
$2.35B
| $18M | ﹤0.01% |
543,153
+66,775
| +14% | +$2.21M |
|
2008
Stantec
STN
$12.6B
| $18M | ﹤0.01% |
215,049
+27,060
| +14% | +$2.26M |
|
2009
LoveSac
LOVE
$272M
| $18M | ﹤0.01% |
795,011
+26,872
| +3% | +$607K |
|
2010
Orion Group Holdings
ORN
$320M
| $17.9M | ﹤0.01% |
1,882,898
+46,079
| +3% | +$438K |
|
2011
Astronics
ATRO
$1.41B
| $17.8M | ﹤0.01% |
888,942
+40,438
| +5% | +$810K |
|
2012
Prothena Corp
PRTA
$438M
| $17.8M | ﹤0.01% |
861,584
-1,248
| -0.1% | -$25.8K |
|
2013
Lands' End
LE
$480M
| $17.7M | ﹤0.01% |
1,306,044
-99,984
| -7% | -$1.36M |
|
2014
Hudson Technologies
HDSN
$447M
| $17.7M | ﹤0.01% |
2,019,067
+364,117
| +22% | +$3.2M |
|
2015
Designer Brands
DBI
$216M
| $17.7M | ﹤0.01% |
2,595,348
+814,286
| +46% | +$5.56M |
|
2016
InterContinental Hotels
IHG
$18.3B
| $17.7M | ﹤0.01% |
167,215
-5,344
| -3% | -$566K |
|
2017
Green Dot
GDOT
$796M
| $17.7M | ﹤0.01% |
1,870,794
-372,248
| -17% | -$3.52M |
|
2018
Rocket Lab Corporation Common Stock
RKLB
$23B
| $17.7M | ﹤0.01% |
3,678,416
-232,593
| -6% | -$1.12M |
|
2019
Castle Biosciences
CSTL
$643M
| $17.6M | ﹤0.01% |
809,934
+60,675
| +8% | +$1.32M |
|
2020
Bandwidth Inc
BAND
$533M
| $17.6M | ﹤0.01% |
1,043,013
+62,201
| +6% | +$1.05M |
|
2021
Grid Dynamics Holdings
GDYN
$650M
| $17.6M | ﹤0.01% |
1,672,906
+206,201
| +14% | +$2.17M |
|
|
AAT
2022
American Assets Trust
AAT
$1.28B
| $17.4M | ﹤0.01% |
779,127
+69,985
| +10% | +$1.57M |
|
2023
Blue Bird Corp
BLBD
$1.87B
| $17.4M | ﹤0.01% |
323,179
+76,036
| +31% | +$4.09M |
|
2024
Biglari Holdings Class B
BH
$970M
| $17.4M | ﹤0.01% |
89,803
+1,291
| +1% | +$250K |
|
2025
Warner Music
WMG
$17.4B
| $17.3M | ﹤0.01% |
563,942
+138,251
| +32% | +$4.24M |
|